METEOR registry analysis of data from 12 countries shows association between socioeconomic status of a country and disease activity in RA patients. Biologic DMARDs when available in poorer countries had less than expected effect on disease activity, Bergstra SA #ACR18

The RISE registry showed that for 50% of RA patients, medication remained unchanged over the follow-up period, despite moderate to high disease activity. The treatment least likely to be altered was the combination of MTX and a biologic, Curtis J #ACR18

REMORA app and wearables provided data that showed positive outcomes with better information about short-lived flares, better self-awareness of the disease and better conversations and more personalised care, Dixon W #ACR18

checkpoint inhibitor-related myositis associated with poor outcomes. #2976 @RheumNow @HealioRheum #ACR18

Great summary in the ⁦@ACRheum⁩ Daily News of the ‘2018 Great Debate examines questions about hydroxychloroquine dosing guidelines’ #ACR18 https://t.co/ZKkrcixo5v

• https://www.acrdailynewslive.org/2018-great-debate-examines-questions-about-hyd…

Would you leave ABIM and join alternate board certification bodies (eg: ABAI: American Board of Allergy and Immunology). ACR is looking into making a new combined board Am Board if Allergy, Immunology, and Rheumatology — ABAIR

This comes up in real life, and will challenge your clinical skills. #ACR18 https://t.co/O03w6J9r9e

• k dao on Twitter: "J Olin’s PEARL: “if you see a string of beads on arteri…

Digital pain reduction kit. VR device and TENS unit. #ACR18 https://t.co/pwD2B15HSv

Questions about checkpoint inhibitors: Are immune-related AEs predicative of cancer therapy response? Will immunosuppressives required to treat patients with immune related AEs blunt the anti-tumoural effects? Mixed results to date. @RheumNow #ACR18

Fun fact: Anti-Ro and -La were named after patients named Robair and Latiner 🤓 #lupus #ACR18 @RheumNow

This is why it's important that rheumatologists discuss contraception and family planning with their patients. https://t.co/9YPNGsZsGP

• Ian N Bruce on Twitter: "#ACR18 @RheumNow abs 2653. Worryingly over 50% of…

There is NO reason to withhold folate on day of MTX. Folic acid does not enter the cell via the RFC (folinic acid does). Therefore no evidence for competition. - Dr Joel Kremer @RheumNow #ACR18 🤔

Want to help reduce the wait time for people to get in to see a rheumatologist? Donate to the ACR Rheum Research Foundation! In addition to funding research to cure arthritis, @RheumResearch funds training programs like the one I trained at #Georgetown #ACR18 https://t.co/dfkrdLlaNE

Breast feeding update in Rheumatic Patients: TNF inhibitors as a class are compatible with breast feeding. Prednisone doses < 20 mg/day OK for breast feeding. Patients on higher doses should delay breast feeding for four hours after administration #ACR18 #CleClinicRheum

#ACR18 Short term relief during breastfeeding: 🌼 NSAIDs are compatible (ibuprofen preferred - short acting) 🌼 prednisone <20mg a day compatible 🌼 if using prednisone >20mg a day, then delay breastfeeding or discard milk for 4hr after administration